HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PP regimen

chemotherapy protocol consisting of above cpds; used in treatment ovarian carcinoma

Networked: 7 relevant articles (3 outcomes, 1 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1.	Al Shamsi, Hefsa Rashed: 1 article (01/2022)
2.	Aziz, David: 1 article (01/2022)
3.	Shaheen, Ihab: 1 article (01/2022)
4.	Li, Zengyun: 1 article (05/2017)
5.	Ma, Qingtong: 1 article (05/2017)
6.	Wang, Dongqing: 1 article (05/2017)
7.	Zhang, Peiliang: 1 article (05/2017)
8.	Zhou, Tao: 1 article (05/2017)
9.	Fang, Xue-Feng: 1 article (02/2015)
10.	Shen, Hong: 1 article (02/2015)

Related Diseases

1.	Proteinuria 10/01/2011 - "Reduction of proteinuria was rapidly induced by plasmapheresis (PP) and the patient has remained in remission with a once-weekly PP regimen, which has now been continued for >3½ years. " 01/01/2022 - "One study suggested intensified PP regimen while in most other studies PP was guided by the response reflected by the reduction of proteinuria. "
2.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/01/2015 - "In patients with advanced non-squamous non-small cell lung cancer (NSCLC), a pemetrexed/cisplatin (PP) regimen is considered as one of the preferred first-line treatments. " 01/01/2011 - "Whether pemetrexed plus platinum (PP) regimen is superior to gemcitabine plus platinum (GP) regimen for patients with advanced non-small cell lung cancer (NSCLC) is unclear. "
3.	Postmenopausal Osteoporosis 05/01/1999 - "The safety and efficacy of tibolone (Livial) were compared with the traditional cyclic, sequential conjugated estrogens/medroxyprogesterone acetate (Premarin/Provera; PP) regimen for the treatment of climacteric symptoms, prevention of postmenopausal bone loss, endometrial stimulation and influence on lipid profile. "
4.	Residual Neoplasm 01/01/2000 - "The PP regimen was also significantly superior in patients with macroscopic residual tumor after the initial operation, and the 5-year survival rates were 25.7 and 10.1% in the PP and PVB groups, respectively (p = 0.0128). "
5.	Esophagitis 05/01/2017 - "Therefore, chemoradiotherapy with the PP regimen achieved therapeutic results comparable with those of the PF regimen; in terms of toxicity, the incidence of hematological toxicity was higher and that of esophagitis was lower with the PP regimen."

Related Drugs and Biologics

1.	Pemetrexed (MTA)
2.	Medroxyprogesterone Acetate (Depo-Provera)
3.	Platinum
4.	Lipids
5.	Conjugated (USP) Estrogens (Premarin)
6.	Gemcitabine
7.	tibolone
8.	Cisplatin (Platino)

Related Therapies and Procedures

1.	Plasmapheresis
2.	Chemoradiotherapy